feed,title,long_url,short_url
BioRxiv,An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines,https://biorxiv.org/cgi/content/short/2020.11.18.388934v1?rss=1,https://j.mp/32WVjOF
BioRxiv,Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma,https://biorxiv.org/cgi/content/short/2020.11.18.388991v1?rss=1,https://j.mp/3kKcOb5
BioRxiv,HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19,https://biorxiv.org/cgi/content/short/2020.11.18.388983v1?rss=1,https://j.mp/36MkCUN
